ABEO logo

Abeona Therapeutics Inc. (ABEO)

Profile

Full Name

Abeona Therapeutics Inc.

Ticker

NASDAQ: ABEO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 19, 1980

Indexes

Not included

Website

https://www.abeonatherapeutics.com

Employees

136

Key Details

Price

$6.49(+1.88%)

Market cap

$332.01M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.55(+38.74% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.49
    ABEO price is $6.49

    30-Day Relative Volume

    0.77
    ABEO 30-day relative volume is 0.77

    Price Performance

    Price Most recent change

    +1.88%
    ABEO price was up +1.88% on Aug 1, 2025

    Price YTD change

    +16.52%
    ABEO price is up +16.52% since January 1st

    Price 1-year change

    +38.09%
    ABEO price is up +38.09% year-on-year

    Price 3-year change

    +52.35%
    ABEO price is up +52.35% over the past 3 years

    Price Range

    Price All-time high

    $5.44M
    ABEO price is currently -100.00% below its historical high of $5.44 million

    Price 3-year low

    $2.19
    ABEO price is currently +196.35% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $332.01M
    ABEO market capitalization is $332.01 million

    Market cap 3-year change

    +1209.76%
    ABEO market capitalization is up +1209.76% over the past 3 years

    Market cap All-time high

    $1.01B
    ABEO market capitalization is currently -67.28% below its historical high of $1.01 billion

    Market cap sector rank

    60.36%
    ABEO market capitalization is higher than 60.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.79%
    ABEO shares outstanding is up +22.79% year-on-year

    Shares Outstanding 3-Year Change

    +759.72%
    ABEO shares outstanding is up +759.72% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.69
    ABEO beta is 0.69

    200-day SMA

    $5.79
    ABEO price is currently +12.02% above its 200-day simple moving average

    50-day SMA

    $6.21
    ABEO price is currently +4.50% above its 50-day simple moving average

    RSI

    54.13
    ABEO 14-day relative strength index is 54.13

    Volume

    0.77
    ABEO 30-day relative volume is 0.77

    ATR

    $0.34
    ABEO average true range is $0.34

    10-day Historical Volatility

    47.23%
    ABEO 10-day historical volatility is 47.23%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ABEO annual revenue value is unknown

    Revenue Analysts estimate

    $47.91M
    ABEO annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    ABEO annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ABEO annual revenue is unknown

    EPS

    EPS

    -$1.55
    ABEO annual earnings per share is -$1.55

    EPS Analysts estimate

    -$0.46
    ABEO annual earnings per share is currently +236.96% higher than the consensus analysts' forecast

    EPS 1-year change

    +38.74%
    ABEO annual earnings per share is up +38.74% year-on-year

    EPS Sector rank

    45.14%
    ABEO annual earnings per share is higher than 45.14% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    ABEO annual gross profit is $0.00

    Gross margin

    -
    ABEO annual gross profit margin value is unknown

    Operating profit

    -$64.21M
    ABEO annual operating income is -$64.21 million

    Operating margin

    -
    ABEO annual operating profit margin value is unknown

    Net income

    -$63.73M
    ABEO annual net profit is -$63.73 million

    Net margin

    -
    ABEO annual net profit margin value is unknown

    Expenses

    Total expenses

    $64.21M
    ABEO annual total expenses is $64.21 million

    Operating expenses

    $64.21M
    ABEO annual total operating expenses is $64.21 million

    Cost of goods sold

    -
    ABEO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $29.85M
    ABEO annual SGA is $29.85 million

    Depreciation and amortization

    $2.91M
    ABEO annual depreciation & amortization is $2.91 million

    Interest expense

    $4.21M
    ABEO annual interest expense is $4.21 million

    Income tax

    -
    ABEO annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$59.53M
    ABEO annual earnings before interest & taxes is -$59.53 million

    EBITDA

    -$56.62M
    ABEO annual EBITDA is -$56.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $108.93M
    ABEO annual total assets is $108.93 million

    Non current assets

    $8.08M
    ABEO annual long term assets is $8.08 million

    Current assets

    $100.85M
    ABEO annual total current assets is $100.85 million

    Cash and cash equivalents

    $23.36M
    ABEO annual cash & cash equivalents is $23.36 million

    Accounts receivable

    -
    ABEO annual accounts receivable value is unknown

    Inventory

    -
    ABEO annual inventory value is unknown

    Liabilities

    Total liabilities

    $64.90M
    ABEO annual total liabilities is $64.90 million

    Long term liabilities

    $48.31M
    ABEO annual total long term liabilities is $48.31 million

    Current liabilities

    $16.59M
    ABEO annual total current liabilities is $16.59 million

    Accounts payable

    $3.44M
    ABEO annual accounts payable is $3.44 million

    Debt

    Total debt

    $23.05M
    ABEO annual total debt is $23.05 million

    Total debt 1-year change

    +326.81%
    ABEO annual total debt is up +326.81% year-on-year

    Long term debt

    $16.30M
    ABEO annual long term debt is $16.30 million

    Short term debt

    $6.75M
    ABEO annual short term debt is $6.75 million

    Equity & Capital

    Shareholders equity

    $44.03M
    ABEO annual stockholders equity is $44.03 million

    Book value

    $44.03M
    ABEO annual book value is $44.03 million

    Retained earnings

    -$813.26M
    ABEO annual retained earnings is -$813.26 million

    Working capital

    $84.27M
    ABEO annual working capital is $84.27 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$56.02M
    ABEO annual cash flow from operations is -$56.02 million

    Cash from operations 1-year change

    -51.36%
    ABEO annual cash flow from operations is down -51.36% year-on-year

    Cash from investing

    -$39.24M
    ABEO annual cash flow from investing activities is -$39.24 million

    Cash from investing 1-year change

    -18965.38%
    ABEO annual cash flow from investing activities is down -18965.38% year-on-year

    Cash from financing

    $104.14M
    ABEO annual cash flow from financing activities is $104.14 million

    Cash from financing 1-year change

    +181.02%
    ABEO annual cash flow from financing activities is up +181.02% year-on-year

    CAPEX

    CAPEX

    -
    ABEO annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ABEO annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$58.46M
    ABEO annual free cash flow is -$58.46 million

    Free cash flow 1-year change

    -56.56%
    ABEO annual free cash flow is down -56.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ABEO annual gross profit margin value is unknown

    Operating margin

    -
    ABEO annual operating profit margin value is unknown

    Net margin

    -
    ABEO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -58.51%
    ABEO annual return on assets is -58.51%

    ROE

    -144.75%
    ABEO annual return on equity is -144.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ABEO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ABEO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.02
    ABEO price to book ratio is 8.02

    PB ratio Sector rank

    86.97%
    ABEO price to book ratio is higher than 86.97% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ABEO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ABEO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $340.05M
    ABEO enterprise value is $340.05 million

    Enterprise value Sector rank

    61.12%
    ABEO enterprise value is higher than 61.12% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.21
    ABEO EV/EBITDA is -9.21

    EV/EBITDA Sector rank

    14.77%
    ABEO EV/EBITDA is higher than 14.77% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.08
    ABEO annual current ratio is 6.08

    Quick ratio

    -
    ABEO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.52
    ABEO annual debt to equity ratio is 0.52

    Interest coverage ratio

    -14.15
    ABEO annual interest coverage ratio is -14.15

    Risk & Stability

    Piotroski F-Score

    -
    ABEO piotroski f-score value is unknown

    Altman Z-Score

    -
    ABEO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 16, 25 HC Wainwright & Co.
    Buy
    Jul 14, 25 HC Wainwright & Co.
    Buy
    May 16, 25 Stifel
    Buy
    Apr 30, 25 HC Wainwright & Co.
    Buy
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 Oppenheimer
    Outperform
    Feb 19, 25 HC Wainwright & Co.
    Buy
    Nov 25, 24 HC Wainwright & Co.
    Buy
    Oct 31, 24 HC Wainwright & Co.
    Buy
    Oct 29, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with ABEO included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Abeona Therapeutics Inc.?
    • Does Abeona Therapeutics Inc. pay dividends?
    • What sector is Abeona Therapeutics Inc. in?
    • What industry is Abeona Therapeutics Inc. in?
    • What country is Abeona Therapeutics Inc. based in?
    • When did Abeona Therapeutics Inc. go public?
    • Is Abeona Therapeutics Inc. in the S&P 500?
    • Is Abeona Therapeutics Inc. in the NASDAQ 100?
    • Is Abeona Therapeutics Inc. in the Dow Jones?
    • When was Abeona Therapeutics Inc.'s last earnings report?
    • When does Abeona Therapeutics Inc. report earnings?

    What is the ticker symbol for Abeona Therapeutics Inc.?

    The ticker symbol for Abeona Therapeutics Inc. is NASDAQ:ABEO

    Does Abeona Therapeutics Inc. pay dividends?

    No, Abeona Therapeutics Inc. does not pay dividends

    What sector is Abeona Therapeutics Inc. in?

    Abeona Therapeutics Inc. is in the Healthcare sector

    What industry is Abeona Therapeutics Inc. in?

    Abeona Therapeutics Inc. is in the Biotechnology industry

    What country is Abeona Therapeutics Inc. based in?

    Abeona Therapeutics Inc. is headquartered in United States

    When did Abeona Therapeutics Inc. go public?

    Abeona Therapeutics Inc.'s initial public offering (IPO) was on September 19, 1980

    Is Abeona Therapeutics Inc. in the S&P 500?

    No, Abeona Therapeutics Inc. is not included in the S&P 500 index

    Is Abeona Therapeutics Inc. in the NASDAQ 100?

    No, Abeona Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Abeona Therapeutics Inc. in the Dow Jones?

    No, Abeona Therapeutics Inc. is not included in the Dow Jones index

    When was Abeona Therapeutics Inc.'s last earnings report?

    Abeona Therapeutics Inc.'s most recent earnings report was on May 15, 2025

    When does Abeona Therapeutics Inc. report earnings?

    The next expected earnings date for Abeona Therapeutics Inc. is August 12, 2025
    On this page